Candida albicans and Candida glabrata, NAA

Detect the presence of Candida albicans and Candida glabrataDNA in vaginal samples as an aid to the diagnosis of vulvovaginal candidiasis in symptomatic women.

This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.